Dishman Carbogen Amcis Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Dishman Carbogen Amcis.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 22.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Fly 28% But Investors Aren't Buying For Growth
Dec 04
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet
Oct 15Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge
Jun 01Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
Feb 25Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt
Dec 29Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?
Jun 22Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?
Feb 14Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky
Jun 22Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings
May 18Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet
Mar 14We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt
Aug 23Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching
Apr 29Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet
Mar 16A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns
Feb 23How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?
Feb 05Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?
Jan 23
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation
Jan 10Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?
Dec 23Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt
Dec 05Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate
Nov 17If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%
Oct 23What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation
Sep 27Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?
Sep 06Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk
Aug 03Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings
Jul 20Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings
Jul 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dishman Carbogen Amcis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 26,186 | -1,740 | -386 | 2,244 | N/A |
| 6/30/2024 | 24,162 | -2,480 | N/A | N/A | N/A |
| 3/31/2024 | 26,158 | -1,534 | 807 | 3,840 | N/A |
| 12/31/2023 | 25,796 | -1,542 | N/A | N/A | N/A |
| 9/30/2023 | 25,683 | -477 | -862 | 3,388 | N/A |
| 6/30/2023 | 25,957 | -168 | N/A | N/A | N/A |
| 3/31/2023 | 24,129 | -298 | -3,537 | 2,660 | N/A |
| 12/31/2022 | 23,634 | -37 | N/A | N/A | N/A |
| 9/30/2022 | 22,856 | -152 | -3,383 | 2,082 | N/A |
| 6/30/2022 | 21,306 | 60 | N/A | N/A | N/A |
| 3/31/2022 | 21,407 | 180 | -1,089 | 3,549 | N/A |
| 12/31/2021 | 21,013 | -724 | N/A | N/A | N/A |
| 9/30/2021 | 20,078 | -1,239 | 946 | 5,777 | N/A |
| 6/30/2021 | 19,884 | -1,277 | N/A | N/A | N/A |
| 3/31/2021 | 19,120 | -1,651 | 1,466 | 5,127 | N/A |
| 12/31/2020 | 18,946 | 419 | N/A | N/A | N/A |
| 9/30/2020 | 19,683 | 908 | 2,848 | 5,893 | N/A |
| 6/30/2020 | 19,961 | 1,246 | N/A | N/A | N/A |
| 3/31/2020 | 20,436 | 1,585 | 1,766 | 5,851 | N/A |
| 12/31/2019 | 21,812 | 1,837 | N/A | N/A | N/A |
| 9/30/2019 | 21,179 | 2,022 | N/A | N/A | N/A |
| 6/30/2019 | 20,983 | 2,050 | N/A | N/A | N/A |
| 3/31/2019 | 20,586 | 2,103 | -261 | 2,820 | N/A |
| 12/31/2018 | 18,924 | 1,862 | N/A | N/A | N/A |
| 9/30/2018 | 18,745 | 1,768 | N/A | N/A | N/A |
| 6/30/2018 | 18,826 | 1,812 | N/A | N/A | N/A |
| 3/31/2018 | 16,948 | 1,546 | N/A | 2,265 | N/A |
| 12/31/2017 | 17,854 | 1,537 | N/A | N/A | N/A |
| 9/30/2017 | 16,840 | 1,383 | N/A | N/A | N/A |
| 6/30/2017 | 16,778 | 1,282 | N/A | N/A | N/A |
| 3/31/2017 | 17,194 | 1,454 | N/A | 3,026 | N/A |
| 12/31/2016 | 12,038 | 953 | N/A | N/A | N/A |
| 3/31/2016 | 68 | 9 | N/A | 15 | N/A |
| 3/31/2015 | N/A | -5 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DCAL's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if DCAL's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if DCAL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if DCAL's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if DCAL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DCAL's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dishman Carbogen Amcis Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shikha Jain | Anand Rathi Shares and Stock Brokers Limited |
| Nikhil Shetty | BP Wealth Management Private Limited |
| Nitin Agarwal | DAM Capital Advisors |